News

In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind ...
In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story ...
A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may ...
Host-pathogen interactions continue to challenge the fields of immunology and infectious disease research, as pathogens deploy a range of strategies to ...